Clinical Trial Update: Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Alternative) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for CHARM Alternative evaluating candesartan in congestive heart failure; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Candesartan (candesartan)

Snippet

Sponsor: AstraZeneca | Conditions: Congestive Heart Failure | Phase 3 | Status: COMPLETED